Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 172741000087118 | BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 172751000087115 | BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 172941000087116 | Anth BioThrax EBOL | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | est un(e) (attribut) | Anth anthrax unspecfied | true | Inferred relationship | Some | ||
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | Has supplier | Emergent BioDefense Operations Lansing LLC (supplier) | true | Inferred relationship | Some | ||
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | a pour principe actif (attribut) | Antigen of Bacillus anthracis (substance) | true | Inferred relationship | Some | 1 | |
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| BioThrax 50 micrograms per 0.5 milliliter suspension for injection Emergent BioDefense Operations Lansing LLC (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR